Financial cost of amyotrophic lateral sclerosis: a case study

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):54-7. doi: 10.3109/21678421.2014.951946. Epub 2014 Sep 23.

Abstract

There are only a few recently published reports of the cost of amyotrophic lateral sclerosis (ALS) care in the United States. Our objectives were to: 1) report annual and disease-duration costs; 2) provide costs related to specific care and services; 3) present costs by payor; and 4) identify strategies and resources that can be offered to patients to assist with the financial burden of ALS. Over a 10-year period (2001-2010), all expenses related to the cost of care for an individual patient were collected concurrently and then analyzed in 2012. Results showed that total disease-duration costs were $1,433,992 (85% paid by insurance, 9% paid by family, 6% paid by charities). The highest costs were for in-home caregivers ($669,150), ventilation ($212,430) and hospital care ($114,558). In conclusion, this case study illustrates costs of care for ALS as a burden for patients that may impact treatment decisions. Charity organizations and insurance case-managers provide services to patients that can help reduce this burden. Costs for specific services as well as resources identified by this study offer physicians and other healthcare providers data-based cost of care information and strategies to share with their patients.

Keywords: Amyotrophic lateral sclerosis; home care; patient care costs.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis / economics*
  • Amyotrophic Lateral Sclerosis / therapy
  • Cost of Illness*
  • Humans
  • Longitudinal Studies
  • Male
  • Retrospective Studies
  • Young Adult